Pooja Khatri is an expert in Neurology at University of Cincinnati (United States). As of October 2026, ScienceLeadR ranks Pooja Khatri in the top 1% of experts worldwide for Cerebrovascular Disorders. Pooja Khatri has authored 558 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 3 of them ongoing. SLR score: 2,485 (community average: 125). How the SLR is computed.

LeadR Profile

Pooja Khatri University of Cincinnati United States
2 485 ScienceLeadR Reputation 2485
Network Map

Neurology

Subspecialties: Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1999 - 2026

Source: PubMed

University of Cincinnati

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 558

Citations

Citations: 38 992 1st author: 35 Last author: 60 Unique author: 8


Breakdown by type

Click a legend label to hide or show it in the chart.

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 3 10
N/A 5
Phase 2 4
Phase 4 2

By status:

Completed 12
Active not recruiting 3
Recruiting 3
Terminated 3

By type:

Interventional 18
Observational 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 2
multicentric5to9 0
multicentricup10 16

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
StrokeNet Thrombectomy Endovascular Platform
NCT06289985 — genes, pol, ischemic stroke, stroke, antihypertensive agents, cholesterol, practice management, therapeutics, practice management, medical, thrombectomy, catheters
N/ARecruiting2025
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future Higher Yield Trials
NCT05338697 — evoked potentials, hospitalization, ischemic stroke, stroke, recycling, evoked potentials, motor, biomarkers, transcranial magnetic stimulation
N/ARecruiting2022
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
NCT03496883 — cerebral hemorrhage, hemorrhage, blood, stroke, hemorrhagic stroke, blood pressure, factor viia, therapeutics, factor vii
Phase 3Active not recruiting2021

LeadR Networks

Main global connection map